Shattuck Labs Inc
STTK0.755USD
+0.023+3.11%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
36.15MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Shattuck Labs Inc Unternehmen
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Unternehmensinformationen
BörsenkürzelSTTK
Name des UnternehmensShattuck Labs Inc
IPO-datumOct 09, 2020
CEODr. Taylor Schreiber, M.D., Ph.D.
Anzahl der mitarbeiter44
WertpapierartOrdinary Share
GeschäftsjahresendeOct 09
Addresse500 W. 5Th Street
StadtAUSTIN
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl78701
Telefon15129004690
Websitehttps://www.shattucklabs.com/
BörsenkürzelSTTK
IPO-datumOct 09, 2020
CEODr. Taylor Schreiber, M.D., Ph.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tyler Brous
Mr. Tyler Brous
Independent Director
Independent Director
238.09K
--
Ms. Casi Deyoung
Ms. Casi Deyoung
Chief Business Officer
Chief Business Officer
81.47K
-8.97%
Dr. Stephen Stout, Ph.D.
Dr. Stephen Stout, Ph.D.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
73.47K
-1.30%
Dr. Taylor Schreiber, M.D., Ph.D.
Dr. Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
71.00K
--
Dr. George S. Golumbeski, Ph.D.
Dr. George S. Golumbeski, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
54.61K
--
Dr. Neil W. Gibson ,Ph.D.
Dr. Neil W. Gibson ,Ph.D.
Independent Director
Independent Director
52.74K
--
Ms. Helen M. Boudreau
Ms. Helen M. Boudreau
Independent Director
Independent Director
--
--
Dr. Kate Sasser, Ph.D.
Dr. Kate Sasser, Ph.D.
Independent Director
Independent Director
--
--
Mr. Conor Richardson, CPA
Mr. Conor Richardson, CPA
Senior Director, Finance & Investor Relations
Senior Director, Finance & Investor Relations
--
--
Dr. Clay Siegall, Ph.D.
Dr. Clay Siegall, Ph.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tyler Brous
Mr. Tyler Brous
Independent Director
Independent Director
238.09K
--
Ms. Casi Deyoung
Ms. Casi Deyoung
Chief Business Officer
Chief Business Officer
81.47K
-8.97%
Dr. Stephen Stout, Ph.D.
Dr. Stephen Stout, Ph.D.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
73.47K
-1.30%
Dr. Taylor Schreiber, M.D., Ph.D.
Dr. Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
71.00K
--
Dr. George S. Golumbeski, Ph.D.
Dr. George S. Golumbeski, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
54.61K
--
Dr. Neil W. Gibson ,Ph.D.
Dr. Neil W. Gibson ,Ph.D.
Independent Director
Independent Director
52.74K
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Prosight Capital
13.86%
Redmile Group, LLC
11.56%
Adage Capital Management, L.P.
9.76%
Hornblower Capital Holdings, LLC
6.04%
Houghton Capital Holdings, LLC
5.45%
Other
53.33%
Aktionäre
Aktionäre
Anteil
Prosight Capital
13.86%
Redmile Group, LLC
11.56%
Adage Capital Management, L.P.
9.76%
Hornblower Capital Holdings, LLC
6.04%
Houghton Capital Holdings, LLC
5.45%
Other
53.33%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
27.18%
Investment Advisor/Hedge Fund
20.42%
Corporation
12.56%
Investment Advisor
11.69%
Family Office
3.41%
Individual Investor
1.95%
Research Firm
0.74%
Bank and Trust
0.08%
Pension Fund
0.02%
Other
21.94%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
185
35.76M
74.65%
-5.95M
2025Q1
190
36.10M
75.45%
-5.76M
2024Q4
182
37.00M
77.49%
-7.77M
2024Q3
191
41.87M
87.75%
-1.86M
2024Q2
194
39.66M
83.35%
+16.66K
2024Q1
209
37.10M
79.60%
-1.39M
2023Q4
203
34.54M
71.04%
+5.75M
2023Q3
205
27.35M
64.28%
-7.93M
2023Q2
215
27.61M
64.91%
-8.42M
2023Q1
223
27.26M
64.10%
-8.88M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Prosight Capital
6.64M
13.86%
--
--
Mar 31, 2025
Redmile Group, LLC
5.54M
11.56%
--
--
Mar 31, 2025
Adage Capital Management, L.P.
4.67M
9.76%
--
--
Mar 31, 2025
Hornblower Capital Holdings, LLC
2.89M
6.04%
--
--
Apr 01, 2025
Houghton Capital Holdings, LLC
2.61M
5.45%
--
--
Apr 01, 2025
BlackRock Institutional Trust Company, N.A.
2.40M
5.01%
-38.62K
-1.59%
Mar 31, 2025
The Vanguard Group, Inc.
2.40M
5.01%
-7.92K
-0.33%
Mar 31, 2025
The Clark Estates Inc.
1.48M
3.08%
--
--
Mar 31, 2025
Pinnacle Associates Ltd.
1.30M
2.71%
-25.00K
-1.89%
Mar 31, 2025
683 Capital Management LLC
1.05M
2.19%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
iShares Russell 2000 Value ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
Texas Capital Texas Equity Index ETF
0%
iShares Russell 2000 ETF
0%
Dimensional US Core Equity 1 ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Morningstar Small-Cap ETF
0%
Texas Capital Texas Small Cap Equity Index ETF
0%
Mehr Anzeigen
iShares Russell 2000 Value ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%
iShares Russell 2000 Growth ETF
Anteil0%
Texas Capital Texas Equity Index ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
Dimensional US Core Equity 1 ETF
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
iShares Morningstar Small-Cap ETF
Anteil0%
Texas Capital Texas Small Cap Equity Index ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
